首页|遗传性凝血因子Ⅶ缺乏症家系遗传学分析

遗传性凝血因子Ⅶ缺乏症家系遗传学分析

扫码查看
目的 分析遗传性凝血因子Ⅶ(FⅦ)缺乏症一家系临床资料,探讨其遗传学病因。方法 2023年4月15日阜外华中心血管病医院遗传性FⅦ缺乏症患者1例,收集先证者及家系成员的临床资料,检测先证者及家系成员凝血常规(凝血酶原时间、活化部分凝血活酶时间等)及凝血因子活性(FⅡ∶C、FⅤ∶C、FⅦ∶C、FⅩ∶C);采用全外显子组测序检测F7基因突变,采用Sanger测序验证突变位点;应用ClustalX2。1软件分析突变位点保守性,PyMOL2。6。0软件预测突变位点蛋白构象变化,ACMG指南评级评估突变致病性。结果 先证者及哥哥凝血酶原时间明显延长,FⅦ:C明显降低,姐姐、儿子、女儿、孙子、外孙FⅦ:C均有不同程度降低,余家系成员FⅦ:C均正常。先证者携带F7基因c。64G>A(p。Gly22Ser)和c。1224T>G(p。His408Gln)复合杂合突变,导致1号外显子编码蛋白的前导序列第22位甘氨酸变为丝氨酸,9号外显子编码蛋白的催化区第408位组氨酸变为谷氨酰胺;哥哥携带与先证者相同的复合杂合突变;女儿、外孙携带F7基因c。64G>A(p。Gly22Ser)杂合突变;姐姐、儿子、孙子携带F7基因c。1224T>G(p。His408Gln)杂合突变;余家系成员为野生型。Gly22在8个同源物种(人类、红原鸡、热带爪蟾、猕猴、家犬、小家鼠、褐家鼠、家牛)FⅦ中非高度保守,在人类维生素K依赖凝血因子FⅦ、FⅨ、FX中高度保守;His408在8个同源物种FⅦ中和人类维生素K依赖凝血因子FⅦ、FⅨ、FX中均高度保守。F7基因c。64G>A(p。Gly22Ser)、c。1224T>G(p。His408Gln)2个突变位点均有文献报道,在dbSNP、1000G、ESP6500、ExAC等数据库均为极低频位点,ACMG指南评级为致病(PS1+PM2+PM3+PP3+PP4+PP5)。结论 F7基因c。64G>A(p。Gly22Ser)和c。1224T>G(p。His408Gln)复合杂合突变是该家系常染色体隐性遗传性FⅦ缺乏症的致病原因,可能影响FⅦ蛋白分子结构而影响其功能,导致血浆FⅦ:C降低,临床表现为轻度或无出血。
Genetic analysis of a family with inherited factor Ⅶ deficiency
Objective To analyze the clinical data of a family with inherited factor Ⅶ(FⅦ)deficiency,and to explore its genetic etiology.Methods A patient with inherited FⅦ deficiency was diagnosed in Fuwai Central China Cardiovascular Hospital on April 15,2023,and the clinical data were collected from the proband and his family members.The coagulation testing(prothrombin time,activated partial thromboplastin time,etc.)and coagulation factors activities(FⅡ∶C,F Ⅴ∶C,FⅦ∶C,FⅩ∶C)were detected.The related variants of F7 gene were detected by whole exome sequencing.The mutation sites were verified by Sanger sequencing.The conservation of mutant sites was analyzed by ClustalX2.1 software.The protein conformation changes of the mutant sites were predicted by PyMOL2.6.0 software.The pathogenicity of the mutations was evaluated by ACMG guideline.Results The prothrombin time of the proband and his brother prolonged significantly,and F Ⅶ:C was significantly reduced.His sister,son,daughter,son's son,and daughter's son had varying degrees of reduced F Ⅶ:C,while the rest of the family members had normal F Ⅶ:C.The proband had compound heterozygous mutations of c.64G>A(p.Gly22Ser)and c.1224T>G(p.His408Gln)in F7 gene,which resulted in the change of glycine to serine at position 22 in the leading sequence coded by exon 1,and histidine to glutamine at position 408 in the catalytic region coded by exon 9.His brother carried the same compound heterozygous mutations.His daughter and daughter's son carried the heterozygous mutation c.64G>A(p.Gly22Ser).His sister,son and son's son carried the heterozygous mutation c.1224T>G(p.His408Gln).The results of the other family members were wild type.Gly22 was not highly conserved in FⅦ of eight homologous species(human,red junglefowl,Xenopus tropicalis,rhesus monkey,dog,house mouse,brown rat,cow),but was highly conserved in human vitamin K-dependent coagulation factors FⅦ,FⅨ and FX.His408 was highly conserved in FⅦ of eight homologous species and in human vitamin K-dependent coagulation factors FⅦ,FⅨ and FX.F7 gene mutation sites c.64G>A(p.Gly22Ser)and c.1224T>G(p.His408Gln)were reported in the literature,and were very low-frequency sites in the databases such as dbSNP,1000G,ESP6500 and ExAC,with ACMG guideline rating of pathogenicity(PS1+PM2+PM3+PP3+PP4+PP5).Conclusion The compound heterozygous mutations of c.64G>A(p.Gly22Ser)and c.1224T>G(p.His408Gln)in F7 gene are the cause of autosomal recessive inherited FⅦ deficiency in this family,which may affect the molecular structure and function of FⅦ protein,resulting in decreased plasma FⅦ:C,with clinical manifestations of mild or no bleeding.

factor Ⅶ deficiencyF7 geneautosomal recessive hereditarygene mutationbioinformatic analysis

乔莹利、宋迪、崔淑方、张绮思、许泼实

展开 >

阜外华中心血管病医院检验科河南省人民医院,河南郑州 451464

中国药科大学生命科学与技术学院,江苏南京 210009

凝血因子Ⅶ缺乏症 F7基因 常染色体隐性遗传 基因突变 生物信息学分析

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(12)